Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for IgG4-related Disease
NCT01584388Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2012
- Primary completion
- Jan 2014
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of rituximab in IgG4-related disease (IgG4-RD), sponsored by Massachusetts General Hospital. Started Apr 2012; status: completed.
02
Drugs
rituximab
03
Conditions
IgG4-related disease (IgG4-RD)
Beyond the preview
Go deeper on NCT01584388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01584388.